Clinical trial

Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of…

NCT00147472 · Ontario Clinical Oncology Group (OCOG), Other · Completed

Key facts

NCT number NCT00147472
Title Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
Official title A Prospective Cohort Study to Determine the Sensitivity of Positron Emission Tomography (PET) in Detecting Metastatic Cancer in Neck Lymph Nodes in Patients With Squamous Cell Head & Neck Cancer Managed With Primary Radiation Therapy
Lead sponsor Ontario Clinical Oncology Group (OCOG), Other
Collaborators Ontario Ministry of Health and Long Term Care
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cancer of the Head and Neck
Intervention type Other
Interventions PET scan in addition to conventional CT imaging
Enrollment 400
Start date May 1, 2004
Primary completion Aug 1, 2009
Completion May 1, 2011
First posted Sep 7, 2005
Last update posted Jun 22, 2012
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies